Baclofen for alcohol use disorder

Clicks: 212
ID: 271892
2018
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
None of the primary or secondary outcomes of the review showed evidence of a difference between baclofen and placebo. The high heterogeneity among primary studies results limits the interpretation of the summary estimate, the identification of moderators and mediators of baclofen's effects on alcoho …
Reference Key
s2018thebaclofen Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Minozzi S;Saulle R;Rösner S;;
Journal The Cochrane database of systematic reviews
Year 2018
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=30484285&dopt=Abstract
Keywords
systematic review meta-analysis National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine female male middle aged Recurrence randomized controlled trials as topic alcohol drinking / prevention & control* patient dropouts / statistics & numerical data baclofen / adverse effects baclofen / therapeutic use* alcoholism / drug therapy* gaba-b receptor agonists / therapeutic use* gaba-b receptor agonists / adverse effects pmid:30484285 pmc6517285 doi:10.1002/14651858.cd012557.pub2 silvia minozzi rosella saulle susanne rösner acamprosate / therapeutic use alcohol deterrents / adverse effects alcohol deterrents / therapeutic use* craving / drug effects depression / chemically induced

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.